nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Sorafenib—liver cancer	0.15	0.269	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.15	0.269	CbGbCtD
Alprazolam—CYP3A5—Sorafenib—liver cancer	0.112	0.201	CbGbCtD
Alprazolam—CYP2C9—Sorafenib—liver cancer	0.0754	0.135	CbGbCtD
Alprazolam—CYP3A4—Sorafenib—liver cancer	0.0438	0.0786	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—liver cancer	0.0266	0.0477	CbGbCtD
Alprazolam—Clonazepam—NAT2—liver cancer	0.00287	0.375	CrCbGaD
Alprazolam—Dyskinesia—Epirubicin—liver cancer	0.00134	0.00484	CcSEcCtD
Alprazolam—Syncope—Sorafenib—liver cancer	0.00133	0.00483	CcSEcCtD
Alprazolam—Dysarthria—Epirubicin—liver cancer	0.00133	0.00481	CcSEcCtD
Alprazolam—Blood bilirubin increased—Epirubicin—liver cancer	0.00133	0.00481	CcSEcCtD
Alprazolam—Loss of consciousness—Sorafenib—liver cancer	0.00131	0.00473	CcSEcCtD
Alprazolam—Coordination abnormal—Epirubicin—liver cancer	0.00128	0.00463	CcSEcCtD
Alprazolam—Myalgia—Sorafenib—liver cancer	0.00127	0.00458	CcSEcCtD
Alprazolam—Arthralgia—Sorafenib—liver cancer	0.00127	0.00458	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00126	0.00455	CcSEcCtD
Alprazolam—Abnormal dreams—Epirubicin—liver cancer	0.00124	0.0045	CcSEcCtD
Alprazolam—Dry mouth—Sorafenib—liver cancer	0.00124	0.00448	CcSEcCtD
Alprazolam—Dyskinesia—Doxorubicin—liver cancer	0.00124	0.00448	CcSEcCtD
Alprazolam—Dysarthria—Doxorubicin—liver cancer	0.00123	0.00445	CcSEcCtD
Alprazolam—Blood bilirubin increased—Doxorubicin—liver cancer	0.00123	0.00445	CcSEcCtD
Alprazolam—Salivary hypersecretion—Epirubicin—liver cancer	0.00122	0.00442	CcSEcCtD
Alprazolam—Infection—Sorafenib—liver cancer	0.00121	0.00436	CcSEcCtD
Alprazolam—Shock—Sorafenib—liver cancer	0.00119	0.00432	CcSEcCtD
Alprazolam—Nervous system disorder—Sorafenib—liver cancer	0.00119	0.00431	CcSEcCtD
Alprazolam—Coordination abnormal—Doxorubicin—liver cancer	0.00119	0.00429	CcSEcCtD
Alprazolam—Skin disorder—Sorafenib—liver cancer	0.00118	0.00427	CcSEcCtD
Alprazolam—Anorexia—Sorafenib—liver cancer	0.00116	0.00419	CcSEcCtD
Alprazolam—Abnormal dreams—Doxorubicin—liver cancer	0.00115	0.00416	CcSEcCtD
Alprazolam—Salivary hypersecretion—Doxorubicin—liver cancer	0.00113	0.00409	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00111	0.004	CcSEcCtD
Alprazolam—Mental disability—Epirubicin—liver cancer	0.00109	0.00395	CcSEcCtD
Alprazolam—Dyspnoea—Sorafenib—liver cancer	0.00108	0.00392	CcSEcCtD
Alprazolam—Dyspepsia—Sorafenib—liver cancer	0.00107	0.00387	CcSEcCtD
Alprazolam—Decreased appetite—Sorafenib—liver cancer	0.00106	0.00382	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Sorafenib—liver cancer	0.00105	0.00379	CcSEcCtD
Alprazolam—Fatigue—Sorafenib—liver cancer	0.00105	0.00379	CcSEcCtD
Alprazolam—Hepatic function abnormal—Epirubicin—liver cancer	0.00104	0.00378	CcSEcCtD
Alprazolam—Constipation—Sorafenib—liver cancer	0.00104	0.00376	CcSEcCtD
Alprazolam—Hepatic failure—Epirubicin—liver cancer	0.00102	0.00368	CcSEcCtD
Alprazolam—Mental disability—Doxorubicin—liver cancer	0.00101	0.00365	CcSEcCtD
Alprazolam—Gastrointestinal pain—Sorafenib—liver cancer	0.000993	0.00359	CcSEcCtD
Alprazolam—Hot flush—Epirubicin—liver cancer	0.000976	0.00353	CcSEcCtD
Alprazolam—Increased appetite—Epirubicin—liver cancer	0.000972	0.00352	CcSEcCtD
Alprazolam—Menopausal symptoms—Epirubicin—liver cancer	0.000968	0.0035	CcSEcCtD
Alprazolam—Hepatic function abnormal—Doxorubicin—liver cancer	0.000967	0.0035	CcSEcCtD
Alprazolam—Urticaria—Sorafenib—liver cancer	0.000965	0.00349	CcSEcCtD
Alprazolam—Abdominal pain—Sorafenib—liver cancer	0.00096	0.00347	CcSEcCtD
Alprazolam—Body temperature increased—Sorafenib—liver cancer	0.00096	0.00347	CcSEcCtD
Alprazolam—Hepatic failure—Doxorubicin—liver cancer	0.00094	0.0034	CcSEcCtD
Alprazolam—Lethargy—Epirubicin—liver cancer	0.000932	0.00337	CcSEcCtD
Alprazolam—Osteoarthritis—Epirubicin—liver cancer	0.000913	0.0033	CcSEcCtD
Alprazolam—Diplopia—Epirubicin—liver cancer	0.000913	0.0033	CcSEcCtD
Alprazolam—Pain in extremity—Epirubicin—liver cancer	0.000913	0.0033	CcSEcCtD
Alprazolam—Hot flush—Doxorubicin—liver cancer	0.000903	0.00327	CcSEcCtD
Alprazolam—Increased appetite—Doxorubicin—liver cancer	0.000899	0.00325	CcSEcCtD
Alprazolam—Affect lability—Epirubicin—liver cancer	0.000899	0.00325	CcSEcCtD
Alprazolam—Menopausal symptoms—Doxorubicin—liver cancer	0.000895	0.00324	CcSEcCtD
Alprazolam—Hypersensitivity—Sorafenib—liver cancer	0.000895	0.00324	CcSEcCtD
Alprazolam—Asthenia—Sorafenib—liver cancer	0.000871	0.00315	CcSEcCtD
Alprazolam—Mood swings—Epirubicin—liver cancer	0.000865	0.00313	CcSEcCtD
Alprazolam—Lethargy—Doxorubicin—liver cancer	0.000862	0.00312	CcSEcCtD
Alprazolam—Pruritus—Sorafenib—liver cancer	0.000859	0.00311	CcSEcCtD
Alprazolam—Ataxia—Epirubicin—liver cancer	0.000859	0.00311	CcSEcCtD
Alprazolam—Osteoarthritis—Doxorubicin—liver cancer	0.000845	0.00306	CcSEcCtD
Alprazolam—Diplopia—Doxorubicin—liver cancer	0.000845	0.00306	CcSEcCtD
Alprazolam—Pain in extremity—Doxorubicin—liver cancer	0.000845	0.00306	CcSEcCtD
Alprazolam—Liver function test abnormal—Epirubicin—liver cancer	0.000843	0.00305	CcSEcCtD
Alprazolam—Affect lability—Doxorubicin—liver cancer	0.000832	0.00301	CcSEcCtD
Alprazolam—Diarrhoea—Sorafenib—liver cancer	0.000831	0.00301	CcSEcCtD
Alprazolam—Breast disorder—Epirubicin—liver cancer	0.000825	0.00298	CcSEcCtD
Alprazolam—Clonazepam—CYP2E1—liver cancer	0.000824	0.108	CrCbGaD
Alprazolam—Nasopharyngitis—Epirubicin—liver cancer	0.000817	0.00295	CcSEcCtD
Alprazolam—Muscular weakness—Epirubicin—liver cancer	0.000805	0.00291	CcSEcCtD
Alprazolam—Dizziness—Sorafenib—liver cancer	0.000803	0.0029	CcSEcCtD
Alprazolam—Mood swings—Doxorubicin—liver cancer	0.0008	0.0029	CcSEcCtD
Alprazolam—Ataxia—Doxorubicin—liver cancer	0.000794	0.00287	CcSEcCtD
Alprazolam—Influenza—Epirubicin—liver cancer	0.000789	0.00285	CcSEcCtD
Alprazolam—Dysphagia—Epirubicin—liver cancer	0.000789	0.00285	CcSEcCtD
Alprazolam—Liver function test abnormal—Doxorubicin—liver cancer	0.00078	0.00282	CcSEcCtD
Alprazolam—Vomiting—Sorafenib—liver cancer	0.000772	0.00279	CcSEcCtD
Alprazolam—Rash—Sorafenib—liver cancer	0.000766	0.00277	CcSEcCtD
Alprazolam—Dermatitis—Sorafenib—liver cancer	0.000765	0.00277	CcSEcCtD
Alprazolam—Breast disorder—Doxorubicin—liver cancer	0.000763	0.00276	CcSEcCtD
Alprazolam—Headache—Sorafenib—liver cancer	0.000761	0.00275	CcSEcCtD
Alprazolam—Nasopharyngitis—Doxorubicin—liver cancer	0.000755	0.00273	CcSEcCtD
Alprazolam—Muscular weakness—Doxorubicin—liver cancer	0.000745	0.0027	CcSEcCtD
Alprazolam—Dysuria—Epirubicin—liver cancer	0.000738	0.00267	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Epirubicin—liver cancer	0.000733	0.00265	CcSEcCtD
Alprazolam—Influenza—Doxorubicin—liver cancer	0.00073	0.00264	CcSEcCtD
Alprazolam—Dysphagia—Doxorubicin—liver cancer	0.00073	0.00264	CcSEcCtD
Alprazolam—Pollakiuria—Epirubicin—liver cancer	0.000729	0.00264	CcSEcCtD
Alprazolam—Nausea—Sorafenib—liver cancer	0.000721	0.00261	CcSEcCtD
Alprazolam—Photosensitivity reaction—Epirubicin—liver cancer	0.00072	0.00261	CcSEcCtD
Alprazolam—Weight increased—Epirubicin—liver cancer	0.000718	0.0026	CcSEcCtD
Alprazolam—Weight decreased—Epirubicin—liver cancer	0.000714	0.00258	CcSEcCtD
Alprazolam—Drowsiness—Epirubicin—liver cancer	0.000704	0.00255	CcSEcCtD
Alprazolam—Infestation—Epirubicin—liver cancer	0.000704	0.00255	CcSEcCtD
Alprazolam—Infestation NOS—Epirubicin—liver cancer	0.000704	0.00255	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000698	0.00252	CcSEcCtD
Alprazolam—Jaundice—Epirubicin—liver cancer	0.000686	0.00248	CcSEcCtD
Alprazolam—Dysuria—Doxorubicin—liver cancer	0.000683	0.00247	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000679	0.00246	CcSEcCtD
Alprazolam—Sweating—Epirubicin—liver cancer	0.000675	0.00244	CcSEcCtD
Alprazolam—Pollakiuria—Doxorubicin—liver cancer	0.000675	0.00244	CcSEcCtD
Alprazolam—Photosensitivity reaction—Doxorubicin—liver cancer	0.000667	0.00241	CcSEcCtD
Alprazolam—Hepatobiliary disease—Epirubicin—liver cancer	0.000665	0.00241	CcSEcCtD
Alprazolam—Weight increased—Doxorubicin—liver cancer	0.000665	0.0024	CcSEcCtD
Alprazolam—Epistaxis—Epirubicin—liver cancer	0.000664	0.0024	CcSEcCtD
Alprazolam—Flunitrazepam—CYP2E1—liver cancer	0.000662	0.0866	CrCbGaD
Alprazolam—Weight decreased—Doxorubicin—liver cancer	0.000661	0.00239	CcSEcCtD
Alprazolam—Infestation NOS—Doxorubicin—liver cancer	0.000651	0.00236	CcSEcCtD
Alprazolam—Infestation—Doxorubicin—liver cancer	0.000651	0.00236	CcSEcCtD
Alprazolam—Drowsiness—Doxorubicin—liver cancer	0.000651	0.00236	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000645	0.00234	CcSEcCtD
Alprazolam—Jaundice—Doxorubicin—liver cancer	0.000635	0.0023	CcSEcCtD
Alprazolam—Hepatitis—Epirubicin—liver cancer	0.000632	0.00229	CcSEcCtD
Alprazolam—Hypoaesthesia—Epirubicin—liver cancer	0.000629	0.00227	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—liver cancer	0.000624	0.00226	CcSEcCtD
Alprazolam—Urinary tract disorder—Epirubicin—liver cancer	0.000624	0.00226	CcSEcCtD
Alprazolam—Oedema peripheral—Epirubicin—liver cancer	0.000622	0.00225	CcSEcCtD
Alprazolam—Connective tissue disorder—Epirubicin—liver cancer	0.000621	0.00225	CcSEcCtD
Alprazolam—Urethral disorder—Epirubicin—liver cancer	0.000619	0.00224	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—liver cancer	0.000616	0.00223	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—liver cancer	0.000614	0.00222	CcSEcCtD
Alprazolam—Erythema multiforme—Epirubicin—liver cancer	0.000597	0.00216	CcSEcCtD
Alprazolam—Nitrazepam—CYP2E1—liver cancer	0.000597	0.0782	CrCbGaD
Alprazolam—Eye disorder—Epirubicin—liver cancer	0.00059	0.00214	CcSEcCtD
Alprazolam—Tinnitus—Epirubicin—liver cancer	0.000589	0.00213	CcSEcCtD
Alprazolam—Cardiac disorder—Epirubicin—liver cancer	0.000586	0.00212	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—liver cancer	0.000584	0.00211	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—liver cancer	0.000582	0.0021	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—liver cancer	0.000577	0.00209	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—liver cancer	0.000576	0.00208	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—liver cancer	0.000574	0.00208	CcSEcCtD
Alprazolam—Angiopathy—Epirubicin—liver cancer	0.000573	0.00207	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—liver cancer	0.000573	0.00207	CcSEcCtD
Alprazolam—Mediastinal disorder—Epirubicin—liver cancer	0.000569	0.00206	CcSEcCtD
Alprazolam—Chills—Epirubicin—liver cancer	0.000567	0.00205	CcSEcCtD
Alprazolam—Ketazolam—ALB—liver cancer	0.000562	0.0735	CrCbGaD
Alprazolam—Mental disorder—Epirubicin—liver cancer	0.000553	0.002	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—liver cancer	0.000553	0.002	CcSEcCtD
Alprazolam—Malnutrition—Epirubicin—liver cancer	0.00055	0.00199	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—liver cancer	0.000546	0.00198	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—liver cancer	0.000545	0.00197	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—liver cancer	0.000542	0.00196	CcSEcCtD
Alprazolam—Tension—Epirubicin—liver cancer	0.00054	0.00195	CcSEcCtD
Alprazolam—Nervousness—Epirubicin—liver cancer	0.000534	0.00193	CcSEcCtD
Alprazolam—Back pain—Epirubicin—liver cancer	0.000532	0.00192	CcSEcCtD
Alprazolam—Flurazepam—CYP2E1—liver cancer	0.000531	0.0695	CrCbGaD
Alprazolam—Angiopathy—Doxorubicin—liver cancer	0.00053	0.00192	CcSEcCtD
Alprazolam—Muscle spasms—Epirubicin—liver cancer	0.000529	0.00191	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—liver cancer	0.000527	0.00191	CcSEcCtD
Alprazolam—Chills—Doxorubicin—liver cancer	0.000524	0.0019	CcSEcCtD
Alprazolam—Vision blurred—Epirubicin—liver cancer	0.000518	0.00187	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—liver cancer	0.000512	0.00185	CcSEcCtD
Alprazolam—Ill-defined disorder—Epirubicin—liver cancer	0.00051	0.00185	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—liver cancer	0.000509	0.00184	CcSEcCtD
Alprazolam—Agitation—Epirubicin—liver cancer	0.000505	0.00183	CcSEcCtD
Alprazolam—Tension—Doxorubicin—liver cancer	0.000499	0.00181	CcSEcCtD
Alprazolam—Malaise—Epirubicin—liver cancer	0.000496	0.00179	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—liver cancer	0.000494	0.00179	CcSEcCtD
Alprazolam—Vertigo—Epirubicin—liver cancer	0.000494	0.00179	CcSEcCtD
Alprazolam—Syncope—Epirubicin—liver cancer	0.000493	0.00178	CcSEcCtD
Alprazolam—Midazolam—CYP2E1—liver cancer	0.000492	0.0644	CrCbGaD
Alprazolam—Back pain—Doxorubicin—liver cancer	0.000492	0.00178	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—liver cancer	0.000489	0.00177	CcSEcCtD
Alprazolam—Palpitations—Epirubicin—liver cancer	0.000486	0.00176	CcSEcCtD
Alprazolam—Loss of consciousness—Epirubicin—liver cancer	0.000483	0.00175	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—liver cancer	0.00048	0.00173	CcSEcCtD
Alprazolam—Convulsion—Epirubicin—liver cancer	0.000476	0.00172	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—liver cancer	0.000472	0.00171	CcSEcCtD
Alprazolam—Arthralgia—Epirubicin—liver cancer	0.000468	0.00169	CcSEcCtD
Alprazolam—Chest pain—Epirubicin—liver cancer	0.000468	0.00169	CcSEcCtD
Alprazolam—Myalgia—Epirubicin—liver cancer	0.000468	0.00169	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—liver cancer	0.000468	0.00169	CcSEcCtD
Alprazolam—Anxiety—Epirubicin—liver cancer	0.000467	0.00169	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000465	0.00168	CcSEcCtD
Alprazolam—Discomfort—Epirubicin—liver cancer	0.000463	0.00167	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—liver cancer	0.000459	0.00166	CcSEcCtD
Alprazolam—Dry mouth—Epirubicin—liver cancer	0.000458	0.00166	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—liver cancer	0.000457	0.00165	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—liver cancer	0.000456	0.00165	CcSEcCtD
Alprazolam—Clonazepam—ALB—liver cancer	0.000453	0.0592	CrCbGaD
Alprazolam—Confusional state—Epirubicin—liver cancer	0.000453	0.00164	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—liver cancer	0.00045	0.00163	CcSEcCtD
Alprazolam—Oedema—Epirubicin—liver cancer	0.000449	0.00162	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—liver cancer	0.000447	0.00162	CcSEcCtD
Alprazolam—Infection—Epirubicin—liver cancer	0.000446	0.00161	CcSEcCtD
Alprazolam—Shock—Epirubicin—liver cancer	0.000442	0.0016	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—liver cancer	0.000441	0.00159	CcSEcCtD
Alprazolam—Nervous system disorder—Epirubicin—liver cancer	0.00044	0.00159	CcSEcCtD
Alprazolam—Tachycardia—Epirubicin—liver cancer	0.000438	0.00158	CcSEcCtD
Alprazolam—Skin disorder—Epirubicin—liver cancer	0.000436	0.00158	CcSEcCtD
Alprazolam—Hyperhidrosis—Epirubicin—liver cancer	0.000434	0.00157	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—liver cancer	0.000433	0.00157	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—liver cancer	0.000433	0.00157	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—liver cancer	0.000433	0.00157	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—liver cancer	0.000432	0.00156	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00043	0.00156	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—liver cancer	0.000428	0.00155	CcSEcCtD
Alprazolam—Anorexia—Epirubicin—liver cancer	0.000428	0.00155	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—liver cancer	0.000424	0.00153	CcSEcCtD
Alprazolam—Diazepam—CYP2E1—liver cancer	0.000422	0.0552	CrCbGaD
Alprazolam—Hypotension—Epirubicin—liver cancer	0.000419	0.00152	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—liver cancer	0.000419	0.00151	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—liver cancer	0.000415	0.0015	CcSEcCtD
Alprazolam—Infection—Doxorubicin—liver cancer	0.000413	0.00149	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000409	0.00148	CcSEcCtD
Alprazolam—Shock—Doxorubicin—liver cancer	0.000409	0.00148	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—liver cancer	0.000407	0.00147	CcSEcCtD
Alprazolam—Insomnia—Epirubicin—liver cancer	0.000406	0.00147	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—liver cancer	0.000405	0.00147	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—liver cancer	0.000403	0.00146	CcSEcCtD
Alprazolam—Paraesthesia—Epirubicin—liver cancer	0.000403	0.00146	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—liver cancer	0.000401	0.00145	CcSEcCtD
Alprazolam—Dyspnoea—Epirubicin—liver cancer	0.0004	0.00145	CcSEcCtD
Alprazolam—Somnolence—Epirubicin—liver cancer	0.000399	0.00144	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—liver cancer	0.000396	0.00143	CcSEcCtD
Alprazolam—Dyspepsia—Epirubicin—liver cancer	0.000395	0.00143	CcSEcCtD
Alprazolam—Decreased appetite—Epirubicin—liver cancer	0.00039	0.00141	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—liver cancer	0.000388	0.0014	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Epirubicin—liver cancer	0.000387	0.0014	CcSEcCtD
Alprazolam—Fatigue—Epirubicin—liver cancer	0.000387	0.0014	CcSEcCtD
Alprazolam—Constipation—Epirubicin—liver cancer	0.000384	0.00139	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000378	0.00137	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—liver cancer	0.000376	0.00136	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—liver cancer	0.000373	0.00135	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—liver cancer	0.00037	0.00134	CcSEcCtD
Alprazolam—Feeling abnormal—Epirubicin—liver cancer	0.00037	0.00134	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—liver cancer	0.000369	0.00134	CcSEcCtD
Alprazolam—Gastrointestinal pain—Epirubicin—liver cancer	0.000367	0.00133	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—liver cancer	0.000366	0.00132	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—liver cancer	0.000361	0.00131	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000358	0.0013	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—liver cancer	0.000358	0.0013	CcSEcCtD
Alprazolam—Urticaria—Epirubicin—liver cancer	0.000357	0.00129	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—liver cancer	0.000355	0.00128	CcSEcCtD
Alprazolam—Body temperature increased—Epirubicin—liver cancer	0.000355	0.00128	CcSEcCtD
Alprazolam—Abdominal pain—Epirubicin—liver cancer	0.000355	0.00128	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—liver cancer	0.000342	0.00124	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—liver cancer	0.00034	0.00123	CcSEcCtD
Alprazolam—Hypersensitivity—Epirubicin—liver cancer	0.000331	0.0012	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—liver cancer	0.00033	0.00119	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—liver cancer	0.000328	0.00119	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—liver cancer	0.000328	0.00119	CcSEcCtD
Alprazolam—Asthenia—Epirubicin—liver cancer	0.000322	0.00116	CcSEcCtD
Alprazolam—Pruritus—Epirubicin—liver cancer	0.000318	0.00115	CcSEcCtD
Alprazolam—Diarrhoea—Epirubicin—liver cancer	0.000307	0.00111	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—liver cancer	0.000306	0.00111	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—liver cancer	0.000298	0.00108	CcSEcCtD
Alprazolam—Dizziness—Epirubicin—liver cancer	0.000297	0.00107	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—liver cancer	0.000294	0.00106	CcSEcCtD
Alprazolam—Vomiting—Epirubicin—liver cancer	0.000285	0.00103	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—liver cancer	0.000284	0.00103	CcSEcCtD
Alprazolam—Rash—Epirubicin—liver cancer	0.000283	0.00102	CcSEcCtD
Alprazolam—Dermatitis—Epirubicin—liver cancer	0.000283	0.00102	CcSEcCtD
Alprazolam—Headache—Epirubicin—liver cancer	0.000281	0.00102	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—liver cancer	0.000275	0.000993	CcSEcCtD
Alprazolam—Nausea—Epirubicin—liver cancer	0.000267	0.000964	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—liver cancer	0.000264	0.000955	CcSEcCtD
Alprazolam—Rash—Doxorubicin—liver cancer	0.000262	0.000947	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—liver cancer	0.000262	0.000946	CcSEcCtD
Alprazolam—Headache—Doxorubicin—liver cancer	0.00026	0.000941	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—liver cancer	0.000247	0.000892	CcSEcCtD
Alprazolam—Diazepam—ALB—liver cancer	0.000232	0.0303	CrCbGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.000139	0.000879	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000138	0.000873	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000137	0.000867	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—BRAF—liver cancer	0.000135	0.000854	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000134	0.000852	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—STAT3—liver cancer	0.000134	0.000851	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TAT—liver cancer	0.000132	0.000837	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—BRAF—liver cancer	0.000131	0.00083	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000129	0.000818	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000129	0.000815	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—BRAF—liver cancer	0.000129	0.000815	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000128	0.000813	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—BRAF—liver cancer	0.000127	0.000801	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—BRAF—liver cancer	0.000126	0.000796	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000126	0.000795	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000125	0.000792	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CYCS—liver cancer	0.000125	0.000789	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000124	0.000786	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—BRAF—liver cancer	0.000123	0.000781	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000122	0.000775	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CYCS—liver cancer	0.00012	0.000762	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CYCS—liver cancer	0.00012	0.000757	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000119	0.000756	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000118	0.000744	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000117	0.000743	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000116	0.000735	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000114	0.000725	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000114	0.000721	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—RAF1—liver cancer	0.000113	0.000713	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000112	0.000706	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—RAF1—liver cancer	0.000109	0.000693	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000109	0.000692	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000108	0.000686	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—BRAF—liver cancer	0.000108	0.000683	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000108	0.000682	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—RAF1—liver cancer	0.000107	0.000681	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—UGDH—liver cancer	0.000107	0.000679	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000107	0.000675	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000106	0.000674	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—RAF1—liver cancer	0.000106	0.000669	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000105	0.000666	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—RAF1—liver cancer	0.000105	0.000664	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000105	0.000663	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000105	0.000662	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000104	0.000658	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—RAF1—liver cancer	0.000103	0.000652	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000103	0.000651	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000103	0.000651	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000103	0.00065	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000102	0.000646	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.000101	0.00064	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000101	0.000639	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—EPT1—liver cancer	0.000101	0.000639	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.0001	0.000635	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	9.97e-05	0.000631	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	9.92e-05	0.000628	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	9.85e-05	0.000624	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—HRAS—liver cancer	9.81e-05	0.000621	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TAT—liver cancer	9.56e-05	0.000605	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	9.37e-05	0.000593	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP2E1—liver cancer	9.28e-05	0.000588	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	9.15e-05	0.00058	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—PPARA—liver cancer	9.01e-05	0.000571	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—RAF1—liver cancer	9.01e-05	0.00057	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GLUL—liver cancer	8.99e-05	0.000569	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CPT1B—liver cancer	8.99e-05	0.000569	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	8.92e-05	0.000565	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—PPARA—liver cancer	8.76e-05	0.000554	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NR1H4—liver cancer	8.67e-05	0.000549	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—AKT1—liver cancer	8.66e-05	0.000548	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	8.61e-05	0.000545	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—PPARA—liver cancer	8.6e-05	0.000544	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTA3—liver cancer	8.52e-05	0.00054	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GGT1—liver cancer	8.52e-05	0.000539	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	8.45e-05	0.000535	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—PPARA—liver cancer	8.39e-05	0.000532	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	8.24e-05	0.000522	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—HRAS—liver cancer	8.1e-05	0.000513	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—HRAS—liver cancer	7.87e-05	0.000498	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTA4—liver cancer	7.79e-05	0.000494	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—HRAS—liver cancer	7.72e-05	0.000489	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTP1—liver cancer	7.65e-05	0.000485	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTA2—liver cancer	7.6e-05	0.000481	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	7.59e-05	0.000481	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	7.58e-05	0.00048	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—UGDH—liver cancer	7.56e-05	0.000479	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	7.56e-05	0.000479	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.55e-05	0.000478	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—HRAS—liver cancer	7.54e-05	0.000478	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	7.41e-05	0.000469	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTA1—liver cancer	7.33e-05	0.000464	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NAT2—liver cancer	7.25e-05	0.000459	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	7.2e-05	0.000456	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—EPT1—liver cancer	7.11e-05	0.00045	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTM1—liver cancer	7.03e-05	0.000445	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALDOB—liver cancer	6.95e-05	0.00044	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	6.94e-05	0.000439	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TAT—liver cancer	6.74e-05	0.000427	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ALB—liver cancer	6.7e-05	0.000424	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.67e-05	0.000422	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.63e-05	0.00042	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CRABP1—liver cancer	6.63e-05	0.00042	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.58e-05	0.000416	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ALB—liver cancer	6.51e-05	0.000412	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GLUL—liver cancer	6.5e-05	0.000411	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CPT1B—liver cancer	6.5e-05	0.000411	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	6.47e-05	0.00041	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ALB—liver cancer	6.39e-05	0.000405	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	6.28e-05	0.000398	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NR1H4—liver cancer	6.27e-05	0.000397	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	6.24e-05	0.000395	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—HRAS—liver cancer	6.2e-05	0.000393	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA3—liver cancer	6.16e-05	0.00039	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	6.13e-05	0.000388	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	6.06e-05	0.000384	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—HRAS—liver cancer	6.03e-05	0.000382	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—HRAS—liver cancer	5.92e-05	0.000375	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—RAF1—liver cancer	5.88e-05	0.000373	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—HRAS—liver cancer	5.82e-05	0.000368	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HPGDS—liver cancer	5.79e-05	0.000367	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—RAF1—liver cancer	5.78e-05	0.000366	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—HRAS—liver cancer	5.78e-05	0.000366	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	5.68e-05	0.00036	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—HRAS—liver cancer	5.67e-05	0.000359	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	5.64e-05	0.000357	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA4—liver cancer	5.63e-05	0.000357	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	5.54e-05	0.000351	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA2—liver cancer	5.49e-05	0.000348	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	5.35e-05	0.000339	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA1—liver cancer	5.3e-05	0.000335	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NAT2—liver cancer	5.24e-05	0.000332	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PSMD10—liver cancer	5.16e-05	0.000327	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PSMA4—liver cancer	5.16e-05	0.000327	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GOT2—liver cancer	5.02e-05	0.000318	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALDOB—liver cancer	5.02e-05	0.000318	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—UGDH—liver cancer	4.99e-05	0.000316	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.96e-05	0.000314	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—HRAS—liver cancer	4.96e-05	0.000314	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	4.84e-05	0.000307	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CRABP1—liver cancer	4.79e-05	0.000303	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2E1—liver cancer	4.72e-05	0.000299	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—EPT1—liver cancer	4.69e-05	0.000297	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CPT1B—liver cancer	4.58e-05	0.00029	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GLUL—liver cancer	4.58e-05	0.00029	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TAT—liver cancer	4.44e-05	0.000281	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYCS—liver cancer	4.42e-05	0.00028	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NR1H4—liver cancer	4.42e-05	0.00028	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA3—liver cancer	4.34e-05	0.000275	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GGT1—liver cancer	4.34e-05	0.000275	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GOT1—liver cancer	4.34e-05	0.000275	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HPGDS—liver cancer	4.19e-05	0.000265	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA4—liver cancer	3.97e-05	0.000251	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—liver cancer	3.89e-05	0.000247	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.88e-05	0.000246	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA2—liver cancer	3.87e-05	0.000245	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMOX1—liver cancer	3.84e-05	0.000243	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA1—liver cancer	3.73e-05	0.000236	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PSMA4—liver cancer	3.73e-05	0.000236	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PSMD10—liver cancer	3.73e-05	0.000236	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NAT2—liver cancer	3.69e-05	0.000234	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GOT2—liver cancer	3.63e-05	0.00023	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—liver cancer	3.58e-05	0.000227	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.55e-05	0.000225	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALDOB—liver cancer	3.54e-05	0.000224	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2E1—liver cancer	3.41e-05	0.000216	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A1—liver cancer	3.39e-05	0.000215	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CRABP1—liver cancer	3.38e-05	0.000214	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYCS—liver cancer	3.19e-05	0.000202	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTHFR—liver cancer	3.16e-05	0.0002	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GOT1—liver cancer	3.13e-05	0.000198	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GGT1—liver cancer	3.13e-05	0.000198	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARA—liver cancer	3.1e-05	0.000196	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.04e-05	0.000193	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CPT1B—liver cancer	3.02e-05	0.000191	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GLUL—liver cancer	3.02e-05	0.000191	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HPGDS—liver cancer	2.95e-05	0.000187	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.93e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NR1H4—liver cancer	2.91e-05	0.000184	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA3—liver cancer	2.86e-05	0.000181	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—liver cancer	2.82e-05	0.000178	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMOX1—liver cancer	2.78e-05	0.000176	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.67e-05	0.000169	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CG—liver cancer	2.66e-05	0.000168	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.64e-05	0.000167	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PSMA4—liver cancer	2.63e-05	0.000167	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PSMD10—liver cancer	2.63e-05	0.000167	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA4—liver cancer	2.62e-05	0.000166	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—liver cancer	2.59e-05	0.000164	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARG—liver cancer	2.56e-05	0.000162	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GOT2—liver cancer	2.56e-05	0.000162	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA2—liver cancer	2.55e-05	0.000162	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA1—liver cancer	2.46e-05	0.000156	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A1—liver cancer	2.45e-05	0.000155	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NAT2—liver cancer	2.44e-05	0.000154	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2E1—liver cancer	2.41e-05	0.000152	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CD—liver cancer	2.34e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALDOB—liver cancer	2.33e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.33e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALB—liver cancer	2.31e-05	0.000146	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTHFR—liver cancer	2.29e-05	0.000145	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYCS—liver cancer	2.25e-05	0.000143	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARA—liver cancer	2.24e-05	0.000142	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CRABP1—liver cancer	2.23e-05	0.000141	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GOT1—liver cancer	2.21e-05	0.00014	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GGT1—liver cancer	2.21e-05	0.00014	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CB—liver cancer	2.04e-05	0.000129	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—liver cancer	1.98e-05	0.000126	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMOX1—liver cancer	1.96e-05	0.000124	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HPGDS—liver cancer	1.95e-05	0.000123	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CG—liver cancer	1.92e-05	0.000122	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARG—liver cancer	1.85e-05	0.000117	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—liver cancer	1.82e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PSMA4—liver cancer	1.74e-05	0.00011	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PSMD10—liver cancer	1.74e-05	0.00011	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A1—liver cancer	1.73e-05	0.000109	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CD—liver cancer	1.69e-05	0.000107	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GOT2—liver cancer	1.69e-05	0.000107	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALB—liver cancer	1.67e-05	0.000106	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTHFR—liver cancer	1.61e-05	0.000102	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2E1—liver cancer	1.59e-05	0.0001	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARA—liver cancer	1.58e-05	0.0001	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYCS—liver cancer	1.48e-05	9.4e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CB—liver cancer	1.47e-05	9.32e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GOT1—liver cancer	1.46e-05	9.23e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GGT1—liver cancer	1.46e-05	9.23e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.42e-05	8.99e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CG—liver cancer	1.35e-05	8.57e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—liver cancer	1.31e-05	8.29e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARG—liver cancer	1.31e-05	8.28e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMOX1—liver cancer	1.29e-05	8.17e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CA—liver cancer	1.24e-05	7.86e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—liver cancer	1.2e-05	7.62e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CD—liver cancer	1.19e-05	7.54e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALB—liver cancer	1.18e-05	7.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A1—liver cancer	1.14e-05	7.22e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTHFR—liver cancer	1.06e-05	6.73e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARA—liver cancer	1.04e-05	6.6e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CB—liver cancer	1.04e-05	6.57e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKT1—liver cancer	1.01e-05	6.42e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CA—liver cancer	8.97e-06	5.68e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CG—liver cancer	8.93e-06	5.65e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARG—liver cancer	8.62e-06	5.46e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CD—liver cancer	7.85e-06	4.97e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALB—liver cancer	7.75e-06	4.91e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKT1—liver cancer	7.33e-06	4.64e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CB—liver cancer	6.84e-06	4.33e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CA—liver cancer	6.33e-06	4.01e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKT1—liver cancer	5.17e-06	3.27e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CA—liver cancer	4.17e-06	2.64e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKT1—liver cancer	3.41e-06	2.16e-05	CbGpPWpGaD
